Balance Sheet

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash $ 181 $ 40
Accounts receivable, net 75 307
Inventories 433 678
Prepaid expenses and other current assets 102 97
Total Current Assets 791 1,122
Equipment, net 120 129
Goodwill 601 800
Intangibles, net 194 492
Other assets 19 19
Total Assets 1,725 2,562
Current Liabilities:    
Accounts payable 295 394
Accrued expenses and other current liabilities 1,183 807
Deferred revenue 154 353
Notes and loans payable, net of discounts 309 469
Line of credit 350 150
Short-term convertible debt and accrued interest, net of discounts and premiums 6,377 4,808
Embedded conversion option liability 2,650 4,284
Tax liability 100 142
Total Current Liabilities 11,418 11,407
Long Term Liabilities:    
Loan payable 8 18
Total Liabilities 11,426 11,425
Commitments and contingencies (Note 12)
Stockholders' Deficit:    
Common stock, 19,995,000,000 shares authorized, $0.0001 par value; 359,075,497 and 894,909 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively 36
Additional paid-in capital 156,150 148,359
Accumulated deficit (165,789) (157,222)
Total PositiveID Corporation Stockholders’ Deficit (9,603) (8,863)
Non-controlling interest in consolidated subsidiary (Note 5) (98)
Total Stockholders’ Deficit (9,701) (8,863)
Total Liabilities and Stockholders’ Deficit 1,725 2,562
Series J Convertible Preferred Stock [Member]    
Stockholders' Deficit:    
Preferred stock, value
Series II Convertible Preferred Stock [Member]    
Stockholders' Deficit:    
Preferred stock, value

Source